Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min

Ross, Lisa L ; Walker, A Sarah ; Lou, Yu ; Tenorio, Allan R ; Gibb, Diana M ; Double, Julia ; Gilks, Charles ; McCoig, Cynthia C ; Munderi, Paula ; Musoro, Godfrey ; Kityo, Cissy M ; Grosskurth, Heiner ; Hakim, James ; Mugyenyi, Peter N ; Cutrell, Amy ; Perger, Teodora ; Shaefer, Mark S Winston, Alan

PloS one, 2019-11, Vol.14 (11), p.e0225199 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível